I am a breastfeeding mother and i want to know if it is safe to use Teofilina [Polish]? Is Teofilina [Polish] safe for nursing mother and child? Does Teofilina [Polish] extracts into breast milk? Does Teofilina [Polish] has any long term or short term side effects on infants? Can Teofilina [Polish] influence milk supply or can Teofilina [Polish] decrease milk supply in lactating mothers?
- DrLact safety Score for Teofilina [Polish] is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of Teofilina [Polish] is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that Teofilina [Polish] does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of Teofilina [Polish] safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
One case of nausea, vomiting and irritability has been described. However, Teofilina [Polish] has been used as treatment of apnea on premature babies. It can enhance milk production by stimulating prolactin release.
An expert panel considers use of Teofilina [Polish] to be acceptable during breastfeeding.[1] Maternal Teofilina [Polish] use may occasionally cause stimulation and irritability and fretful sleep in infants. Newborn and especially preterm infants are most likely to be affected because of their slow elimination and low serum protein binding of Teofilina [Polish]. There is no need to avoid Teofilina [Polish] products; however, keep maternal serum concentrations in the lower part of the therapeutic range and monitor the infant for signs of Teofilina [Polish] side effects. Infant serum Teofilina [Polish] concentrations can help to determine if signs of agitation are due to Teofilina [Polish]. Avoiding breastfeeding for an 2 hours after intravenous or 4 hours after an immediate-release oral Teofilina [Polish] product can decrease the dose received by the breastfed infant. When Teofilina [Polish] is given as an oral sustained-release product, timing of nursing with respect to the dose is of little or no benefit.
Irritability and fretful sleeping occurred in a 3-day-old breastfed infant on days of maternal aminophylline intake of 200 mg every 6 hours. These effects ceased with discontinuation and recurred on rechallenge over the next 9 months. These effects were probably caused by Teofilina [Polish] in breastmilk. Another five infants reported in this paper showed no adverse reactions after maternal Teofilina [Polish] ingestion.[3] Accumulation of Teofilina [Polish] in infant serum appears most likely in neonates and premature infants because they eliminate Teofilina [Polish] slowly.[2][5]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.